Information Provided By:
Fly News Breaks for October 3, 2018
MDT
Oct 3, 2018 | 07:25 EDT
RBC Capital analyst Glenn Novarro raised his price target on Medtronic to $109 and kept his Outperform rating following meetings with the company CEO and CFO. The analyst notes that the discussions were "upbeat" and reflected on the company's "track record of consistent financial performance" driven by "steady innovation and improved execution". Novarro added that the meetings increased his confidence in his FY19 revenue and earnings estimates with the company's growth drivers seen as "numerous" and diversified across its four business segments.